DE69228997T2 - Menschliche il-3-varianten - Google Patents

Menschliche il-3-varianten

Info

Publication number
DE69228997T2
DE69228997T2 DE69228997T DE69228997T DE69228997T2 DE 69228997 T2 DE69228997 T2 DE 69228997T2 DE 69228997 T DE69228997 T DE 69228997T DE 69228997 T DE69228997 T DE 69228997T DE 69228997 T2 DE69228997 T2 DE 69228997T2
Authority
DE
Germany
Prior art keywords
pct
human
variants
sec
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228997T
Other languages
English (en)
Other versions
DE69228997D1 (de
Inventor
Mathew Vadas
Angel Lopez
Mary Shannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medvet Science Pty Ltd
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Publication of DE69228997D1 publication Critical patent/DE69228997D1/de
Application granted granted Critical
Publication of DE69228997T2 publication Critical patent/DE69228997T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69228997T 1991-10-07 1992-10-07 Menschliche il-3-varianten Expired - Fee Related DE69228997T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK874291 1991-10-07
PCT/AU1992/000535 WO1993007171A1 (en) 1991-10-07 1992-10-07 Human il-3 variants

Publications (2)

Publication Number Publication Date
DE69228997D1 DE69228997D1 (de) 1999-05-27
DE69228997T2 true DE69228997T2 (de) 1999-08-26

Family

ID=3775735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228997T Expired - Fee Related DE69228997T2 (de) 1991-10-07 1992-10-07 Menschliche il-3-varianten

Country Status (11)

Country Link
US (1) US5591427A (de)
EP (1) EP0609280B1 (de)
JP (1) JPH07501520A (de)
AT (1) ATE179211T1 (de)
AU (1) AU668364B2 (de)
CA (1) CA2120707A1 (de)
DE (1) DE69228997T2 (de)
DK (1) DK0609280T3 (de)
ES (1) ES2133329T3 (de)
GR (1) GR3030032T3 (de)
WO (1) WO1993007171A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998378A (en) * 1989-08-16 1999-12-07 Chiron Corporation Compositions for the inhibition of TNF hormone formation and uses thereof
US5843693A (en) * 1989-08-16 1998-12-01 Chiron Corporation Assay method for screening for inhibitors of proTNF conversion
US6586222B1 (en) 1989-08-16 2003-07-01 Chiron Corporation Recombinant PR-3 and compositions thereof
JPH08503489A (ja) 1992-11-24 1996-04-16 ジー．ディー．サール アンド カンパニー インターロイキン−３（ｉｌ−３）突然変異ポリペプチド
US6361977B1 (en) * 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6403076B1 (en) 1992-11-24 2002-06-11 S. Christopher Bauer Compositions for increasing hematopoiesis with interleukin-3 mutants
US6436387B1 (en) * 1992-11-24 2002-08-20 G.D. Searle & Co. Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
US6413509B1 (en) * 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US6361976B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Co-administration of interleukin-3 mutant polypeptides with CSF'S for multi-lineage hematopoietic cell production
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US7091319B1 (en) * 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
NZ269766A (en) * 1993-07-28 1998-01-26 Medvet Science Pty Ltd Haemopoietic growth factor antagonists; relates to modified forms of such factors
AU699913B2 (en) * 1993-11-10 1998-12-17 Henry M. Jackson Foundation For The Advancement Of Military Medicine Compositions and method for stimulating antibody release by B lymphocytes
US20050059149A1 (en) * 1993-11-22 2005-03-17 Bauer S. Christopher Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins
WO1995024501A1 (en) 1994-03-07 1995-09-14 Cetus Oncology Corporation Compositions for the inhibition of tnf formation and uses thereof
US6465616B1 (en) 1994-04-08 2002-10-15 Bresagen Limited Interleukin-5 antagonist
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
CA2234045A1 (en) * 1995-10-05 1997-04-10 G.D. Searle & Co. Interleuken-3 (il-3) receptor agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
DE69030937T2 (de) * 1989-08-14 1997-10-09 Gist Brocades Nv Mutanten von Interleukin-3

Also Published As

Publication number Publication date
AU668364B2 (en) 1996-05-02
US5591427A (en) 1997-01-07
DE69228997D1 (de) 1999-05-27
EP0609280B1 (de) 1999-04-21
DK0609280T3 (da) 1999-10-25
ES2133329T3 (es) 1999-09-16
AU2753892A (en) 1993-05-03
CA2120707A1 (en) 1993-04-15
JPH07501520A (ja) 1995-02-16
WO1993007171A1 (en) 1993-04-15
GR3030032T3 (en) 1999-07-30
EP0609280A4 (en) 1994-09-14
ATE179211T1 (de) 1999-05-15
EP0609280A1 (de) 1994-08-10

Similar Documents

Publication Publication Date Title
DE69228997D1 (de) Menschliche il-3-varianten
ATE296799T1 (de) P38-inhibitoren
MY132496A (en) Inhibitors of p38
MY117696A (en) INHIBITORS OF p38
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
DE69230040T2 (de) Biokompatibles implantat für die zeitliche abstimmung der ovulation von stuten
ATE218879T1 (de) Therapeutische verwendungen von bakterizide/permeabilitätserhöhende protein dimer produkte
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
DE69400799D1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
DK0613499T4 (da) Humane IT-4-mutantproteiner
ATE382061T1 (de) Mittel zur induktion von apoptosis und zur therapieanwendung
DE69711078T2 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
DE69704213D1 (de) Bioaromatische dibenzofuranderivate und verwendung in der human- oder tiermedizin und in der kosmetik
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69323191T2 (de) Wasserlösliche retinoide
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
MY129421A (en) INHIBITORS OF p38

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee